ARYA Sciences Acquisition Corp II Contracts & Agreements
72 Contracts & Agreements
- Business Finance (26 contracts)
- Business Operations (4)
- Human Resources (26)
- Intellectual Property (1)
- Mergers & Acquisitions (3)
- Real Estate (2)
- Uncategorized (10)
- First Supplemental Indenture, dated as of August 1, 2024, between Cerevel Therapeutics Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on August 1, 2024)
- Form of Repayment Agreement (Filed With SEC on February 27, 2024)
- Severance Benefits Policy for Senior Vice Presidents and Vice Presidents (Filed With SEC on February 27, 2024)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on February 27, 2024)
- Severance Benefits Policy for Specified C-Suite Executives (Filed With SEC on February 27, 2024)
- Support Agreement, dated as of December 6, 2023, by and among AbbVie Inc., Symphony Harlan, LLC, Symphony Harlan Merger Sub, Inc. and BC Perception Holdings, LP (Filed With SEC on December 7, 2023)
- Agreement and Plan of Merger, dated as of December 6, 2023, by and among AbbVie Inc., Symphony Harlan LLC, Symphony Harlan Merger Sub, Inc., and Cerevel Therapeutics Holdings, Inc (Filed With SEC on December 7, 2023)
- Underwriting Agreement, dated as of October 11, 2023, by and between Cerevel Therapeutics Holdings, Inc. and Goldman Sachs & Co. LLC, as representative of the underwriters (Filed With SEC on October 12, 2023)
- Employment Agreement, dated as of June 12, 2023, between Cerevel Therapeutics, LLC and Paul Burgess (Filed With SEC on August 2, 2023)
- Employment Agreement, dated as of April 14, 2023, between Cerevel Therapeutics, LLC and Susan Altschuller (Filed With SEC on August 2, 2023)
- Employment Agreement, dated as of May 1, 2023, between Cerevel Therapeutics, LLC and Ronald Renaud (Filed With SEC on August 2, 2023)
- Form of Performance Restricted Stock Unit Award Agreement (Filed With SEC on August 2, 2023)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 2, 2023)
- Waiver, dated as of April 27, 2023, by and among Cerevel Therapeutics Holdings, Inc. and the investors party thereto (Filed With SEC on August 2, 2023)
- Indenture, dated as of August 16, 2022, between Cerevel Therapeutics Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on August 16, 2022)
- Underwriting Agreement, dated as of August 11, 2022, by and among Cerevel Therapeutics Holdings, Inc., and Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Jefferies LLC and... (Filed With SEC on August 12, 2022)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934 (Filed With SEC on March 1, 2022)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 1, 2022)
- Separation Agreement, dated as of September 19, 2021, by and between Cerevel Therapeutics, LLC and Kathy Yi (Filed With SEC on November 10, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 29, 2021)
- Non-Employee Director Compensation Policy, as amended on April 8, 2021 (Filed With SEC on May 17, 2021)
- Employment Agreement, dated April 20, 2021, by and between Cerevel Therapeutics, LLC and Scott M. Akamine (Filed With SEC on May 17, 2021)
- Funding Agreement, dated as of April 12, 2021, by and between Cerevel Therapeutics, Inc. and BC Pinnacle Holdings, LP (Filed With SEC on May 17, 2021)
- Funding Agreement, dated as of April 12, 2021, by and between Cerevel Therapeutics, Inc. and NovaQuest Co-Investment Fund XVI, L.P (Filed With SEC on May 17, 2021)
- Employment Agreement, dated April 13, 2021, by and between Cerevel Therapeutics, LLC and Abraham N. Ceesay (Filed With SEC on April 21, 2021)
- Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 24, 2021)
- Form of Subscription Agreement (Filed With SEC on March 24, 2021)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on March 24, 2021)
- Amendment No. 1 to Business Combination Agreement, dated as of October 2, 2020, by and between ARYA Sciences Acquisition Corp II and Cerevel Therapeutics, Inc (Filed With SEC on March 24, 2021)
- Business Combination Agreement, dated as of July 29, 2020, by and among ARYA Sciences Acquisition Corp II, Cassidy Merger Sub 1, Inc. and Cerevel Therapeutics, Inc (Filed With SEC on March 24, 2021)
- Waiver, dated January 20, 2021, by and among Cerevel Therapeutics Holdings, Inc. and the investors party thereto (Filed With SEC on January 21, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on December 9, 2020)
- Employment Agreement, dated November 8, 2019, by and between Cerevel Therapeutics, LLC and Bryan Phillips (Filed With SEC on November 16, 2020)
- Employment Agreement, dated July 7, 2020, by and between Cerevel Therapeutics, LLC and Kathleen Tregoning (Filed With SEC on November 16, 2020)
- Employment Agreement, dated May 9, 2019, by and between Cerevel Therapeutics, LLC and Kathy Yi (Filed With SEC on November 16, 2020)
- Employment Agreement, dated June 25, 2019, by and between Cerevel Therapeutics, LLC and Orly Mishan (Filed With SEC on November 16, 2020)
- Employment Agreement, dated April 1, 2019, by and between Cerevel Therapeutics, LLC and Kenneth DiPietro (Filed With SEC on November 16, 2020)
- Offer Letter, dated August 18, 2019, by and between Cerevel Therapeutics, LLC and Mark Bodenrader (Filed With SEC on November 16, 2020)
- Employment Agreement, dated November 23, 2018, by and between Cerevel Therapeutics, LLC and N. Anthony Coles, and amendments thereto (Filed With SEC on November 2, 2020)
- Amended and Restated Registration and Shareholder Rights Agreement, dated October 27, 2020, by and among Cerevel Therapeutics Holdings, Inc. and the stockholders party thereto (Filed With SEC on November 2, 2020)
- Lease Agreement, by and between Cerevel Therapeutics, LLC and FHF I 131 Dartmouth, LLC, dated January 18, 2019 (Filed With SEC on November 2, 2020)
- Lease Agreement, by and between Cerevel Therapeutics, LLC and DW Propco JK, LLC, dated July 3, 2019, as amended on September 1, 2020 (Filed With SEC on November 2, 2020)
- Forms of Award Agreements under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan (Filed With SEC on November 2, 2020)
- Employment Agreement, dated November 26, 2018, by and between Cerevel Therapeutics, LLC and Ramiro Sanchez, and amendment thereto (Filed With SEC on November 2, 2020)
- Employment Agreement, dated March 16, 2019, by and between Cerevel Therapeutics, LLC and John Renger (Filed With SEC on November 2, 2020)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on November 2, 2020)
- Severance Benefits Policy for Specified C-Suite Executives (Filed With SEC on November 2, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on November 2, 2020)
- Form of Indemnification Agreement (Directors) (Filed With SEC on November 2, 2020)
- Form of Indemnification Agreement (Officers) (Filed With SEC on November 2, 2020)
- Amendment No. 1 to Business Combination Agreement, dated October 2, 2020 (Filed With SEC on October 5, 2020)
- License Agreement, by and between Cerevel Therapeutics, LLC (f/k/a Perception OpCo, LLC) and Pfizer Inc., dated August 13, 2018 (Filed With SEC on August 7, 2020)
- Letter Agreement among the Company, the Sponsor and the Companys officers and directors (Filed With SEC on June 9, 2020)
- Underwriting Agreement among the Company, Jefferies LLC and Goldman Sachs & Co. LLC (Filed With SEC on June 9, 2020)
- Warrant Agreement between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on June 9, 2020)
- Private Placement Units Purchase Agreement between the Company and the Sponsor (Filed With SEC on June 9, 2020)
- Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on June 9, 2020)
- Registration and Shareholder Rights Agreement among the Company, the Sponsor and certain other equityholders named therein (Filed With SEC on June 9, 2020)
- Administrative Services Agreement between the Company and the Sponsor (Filed With SEC on June 9, 2020)
- Form of Underwriting Agreement (Filed With SEC on May 29, 2020)
- Form of Letter Agreement between the Registrant, the Sponsor and each director and officer of the Registrant (Filed With SEC on May 29, 2020)
- Securities Subscription Agreement, dated March 2, 2020, between the Registrant and the Sponsor (Filed With SEC on May 29, 2020)
- Promissory Note, dated as of March 2, 2020, issued to the Sponsor (Filed With SEC on May 29, 2020)
- Form of Administrative Services Agreement between the Registrant and the Sponsor (Filed With SEC on May 29, 2020)
- Form of Indemnity Agreement (Filed With SEC on May 29, 2020)
- Form of Private Placement Units Purchase Agreement between the Registrant and the Sponsor (Filed With SEC on May 29, 2020)
- Form of Registration and Shareholder Rights Agreement among the Registrant, the Sponsor and the Holders signatory thereto (Filed With SEC on May 29, 2020)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 29, 2020)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 29, 2020)
- Specimen Warrant Certificate (Filed With SEC on May 29, 2020)
- Specimen Ordinary Share Certificate (Filed With SEC on May 29, 2020)
- Specimen Unit Certificate (Filed With SEC on May 29, 2020)
